ArticleMaterials today. Bio2022

Novel glucose-responsive nanoparticles based on p-hydroxyphenethyl anisate and 3-acrylamidophenylboronic acid reduce blood glucose and ameliorate diabetic nephropathy.

Qiong Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.